Gene symbol |
Species |
Enzyme |
Editing site(s) |
Editing Type |
PMID |
RADAR |
REDIportal |
Description |
ABCA5 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ADAM22 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ADGRB3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ANAPC5 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ANK3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ARHGEF11 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ARNT2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ASIC2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ATP2B2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ATRNL1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
C10orf113 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
C11orf58 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
C1orf95 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CABP1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CACNB2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CADM2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CADPS |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CCDC84 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CDS2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CERS4 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CLASP1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CLASP2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CNTNAP2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CNTNAP4 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
COA4 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CSMD1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
CTNNA2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
DANT2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
DGCR5 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
DGKZ |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
DLG2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
DLGAP1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
DNAJC6 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
DPP10 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
EPS15 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
FAM155A |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
FGF12 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
FGF14 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
FMNL2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
FRMD4A |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
FTX |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
FUT9 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
GFOD2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
GINS4 |
Human |
ADAR1 |
44 |
A-to-I |
|
|
|
Editing was particularly increased in the 3′UTRs of ATM, GINS4 and POLH transcripts in tumors, which correlated with their mRNA expression.
|
GOLGA3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
GPCPD1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
GPM6A |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
GRM7 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
HLTF |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
HP1BP3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
IBA57 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
IFNGR1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ILDR2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
JMJD1C |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
KATNBL1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
KCNIP4 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
KCNQ3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
KCTD16 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
KHDRBS3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
KIAA1211L |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
KLHL11 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
LAMTOR3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
LIMCH1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
LINC-PINT |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
LOC101928961 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
LOC171391 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
LRRC4C |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MAGI2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MAP4K3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MAPK10 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MATR3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MED13 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
METTL6 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MIAT |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MIR22HG |
Human |
NA |
1 |
NA |
|
|
|
MIR22HG is an RNA gene that hosts the small microRNA, hsa-mir-22, and has demonstrated potential as a biomarker for several cancers. Supported by three independent datasets, MIR22HG is very likely involved in RNA editing regulation process.
|
MON2 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MSRA |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MTPAP |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MTR |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
MTUS1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
NCKAP1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
NOVA1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
NRXN1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
NRXN3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
NSMAF |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
NUP43 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
NXPE3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
OXR1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
PAPD4 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
PCDH9 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
PGK1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
PLCB1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
POLH |
Human |
ADAR1 |
156 |
A-to-I |
|
|
|
Editing was particularly increased in the 3′UTRs of ATM, GINS4 and POLH transcripts in tumors, which correlated with their mRNA expression.
|
PPP2R2B |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
PREPL |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
PTPRD |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
R3HDM1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
RALYL |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
RBM5 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
RELL2 |
Human |
ADAR2 |
1 |
A-to-I |
|
|
|
Exon 9-included CCDC15 and exon 3-included RELL2 isoforms are oncogenic and tumor suppressive, respec- tively. More importantly, ADARs-mediated splicing changes indeed affect tumorigenesis, not merely byproducts of ADARs editing and binding.
|
RGS7 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
RTN3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
RTN4 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SERPINI1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SFXN5 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SHC3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SHISA9 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SHTN1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SLC25A27 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SRSF5 |
Human |
NA |
1 |
NA |
|
|
|
SRSF5 is involved in cancer development. Since most RNA editing events occur in the nucleus before splicing, the timing and space location of SRSF5 in the cell support that this gene is very likely involved in the RNA editing process
|
STRBP |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
SYT1 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
TRIM65 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
TTLL7 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
UBE2D3 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
VEZT |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
VPS13C |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
WDR33 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
XKR4 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
XKR6 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ZNF264 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ZNF37BP |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ZNF529 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ZNF680 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ZNF708 |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|
ZYG11B |
Human |
ADAR1 |
1 |
A-to-I |
|
|
|
RNA editing could contribute towards aberrant synaptic formation in ASD
|